Nordson price target lowered to $285 from $295 at DA Davidson

DA Davidson lowered the firm’s price target on Nordson (NDSN) to $285 from $295 and keeps a Buy rating on the shares after its Q4 results and below-consensus Q1 guidance. The firm has scaled back its organic growth assumptions across each of Nordson’s three reportable segments, the analyst tells investors in a research note. In MFS – Medical and Fluid Solutions – DA Davidson sees growth down low single digits as medical interventional demand has “yet to recover”, the firm adds.